5-Aminolevulinic acid induced fluorescence endoscopy of superficial bladder cancer;Die 5-Aminolavulinsaure-induzierte fluoreszens-endoskopie des oberflachlichen harnblasenkarzinoms

Urologe - Ausgabe B

Volumn 39, Issue 2, 1999, Pages 113-120

  Zaak, D ^a   Hofstetter, A G ^a   Baumgartner, R ^a   Stepp, H ^a   Stepp, H G ^a   Wagner, S ^a   Knuchel R ^b   Schmeller, N ^a   Stiegelmayr, A ^a   Frimberger, D ^a   Kriegmair, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

BLADDER CANCER; CYSTOSCOPY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEODYMIUM LASER; REVIEW; SUPERFICIAL CANCER;

EID: 6544281485     PISSN: 00421111     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001310050282     Document Type: Review

References (27)

1. Althausen AF, Prout GR, Daly JJ (1976) Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116: 575-580
2. Badalament RA, Fair WR, et al. (1988) The relative value of cytometry and cytology in the managment of bladder cancer: the memorial Sloan-Kettering Cancer Center experience. Semin Urol 6: 22-30
3. Filbeck T, Roessler W, et al. (1999) Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol 13: 2 March 1999
4. Fukui I, Yokokawa M, et al. (1983) In vivo staining test with metylene blue for bladder cancer. J Urol 130: 252
5. D'Hallewin MA, Baert L (1996) Initial evaluation of the bladder tumor antigen test in superficial bladder cancer. J Urol 155: 475
6. Heney NM, Ahmed S, et al. (1983) Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086
7. Jichlinski P, Forrer M, et al. (1997) Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following topical application of 5 Aminolevulinic acid: preliminary results. Lasers Surg Med 20: 402-408
8. Jocham D, Baumgartner R, et al. (1989) Die Fluoreszenzdiagnose Porphyrin-markierter urothelialer Tumoren. Urologe 28: 59
9. Kiemeney LA, Witjes JA, et al. (1994) Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch-South-East Co-Operative Urological Group. Br J Urol 73: 164
10. Klän F, Loy V, Huland H (1991 Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146: 316-318
11. Knuchel R, Hartmann A, et al. (1997) Längsschnittuntersuchungen von Patienten mit einfachen Hyperplasien und pTa-Tumoren des Urothels nach Detektion mit 5-ALA. Urologe [A] 37: 27
12. Knuchel R, Turban HJ, et al. (1998) Die Rolle entzündlicher urothelialer Läsionen bei der photodynamischen Diagnostik mit der 5-Aminolävulinsäure. Akt Urol 29: 39
13. Köhrmann KU, Woeste M, et al. (1994) Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 25: 208-213
14. Kriegmair M, Baumgartner R, et al. (1994) Photodynamic diagnosis following topical application of delta-aminolevulinic acid in a rat bladder tumor model. In: Thuroff JW, Miller K, Jocham D (eds) Investigative urology V. Chapman & Hall, London, pp 85-87
15. Kriegmair (1994) Photodynamische Diagnose urothelialer Neoplasien nach intravesikaler Instillation von 5-Aminolävulinsäure. Urologe [A] 33: 270-275
16. Kriegmair M, Baumgartner R, et al. (1996) Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155: 105-110
17. Kriegmair M, Wagner S, Stepp H, Hofstetter A (1997) Fluoreszenzquantifizierung bei der 5-Aminolävulinsäure induzierten Fluoreszenzzystoskopie des Harnblasenkarzinoms. Urologe [A] 37: 50
18. Ley H, Mazeman E, Hall RR, Bennet AH (1996) Results of a european multicenter trial comparing the BARD BTA test to urine cytology in patients suspected of having bladder cancer. J Urol 155: 492 A
19. Mersdorf, Brauers A, et al. (1998) 2nd TUR fOR superficial bladder carcinoma: a must? J Urol 159: 5 [Suppl]
20. Sarosdy MF, deVere White RW, et al. (1995) Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 379
21. Schmeller N, Lohrs U, Hofstetter A (1985) Invivo-Anfärbung maligner Areale durch Methylenblau-Instillation in die Blase. Verh Dtsch Ges Urol 37: 580
22. Soloway MS, Murphy W, Rao MK, Cox C (1978) Serial multiple-site biopsies in patients with bladder cancer. J Urol 120: 57
23. Vögeli TA, Grimm MO, Ackermann R (1998) Prospective Study For Quality control of TUR of bladder tumors By Routine 2nd TUR (ReTUR). J Urol 159: 5 [Suppl]
24. Whitmore WF, Bush IM (1966) Ultraviolet cystoscopy in patients with bladder cancer. J Urol 95: 201
25. Zaak D, Wagner S, et al. (1998) Fluoreszenzquantifizierung bei der der 5-Aminolävulinsäure induzierten Fluoreszenzendoskopie des oberflächlichen Harnblasenkarzinoms. Akt Urol 29: 39
26. Zaak D, Stepp H, et al. (1998) Photodynamische Diagnostik und Therapie des Urothelkarzinoms der Harnblase. In: Schmid L, Wilmanns W (Hrsg) Praktische Onkolgie VIII; Zuckschwerdt, Munchen
27. Zaak D, Knuechel R (1998) Clinical results. In: Baumgartner R, Kriegmair M, Hofstetter A (eds) Fluorescence diagnosis of bladder tumors - fundamentals and results -. Endo-Press, Tuttlingen, pp 37-48